Pfizer asks US officials to OK promising COVID-19 pill

Summary by STAT

Pfizer CEO Albert Bourla said the company will ask the FDA on Tuesday to authorize emergency use of its antiviral pill to combat Covid-19.

Published 2 years ago · Washington, United States

News Articles

More Filters

All

Left

Center

Right

Yahoo News

Pfizer asks US officials to OK promising COVID-19 pill

Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks. It is one of a handful of pills that have recently been shown to significantly cut hospitalizations and deaths among people infected with COVID-19. If authorized by the Food and Drug Administration it could be a major step toward managing the pandemic and returning…

2 years ago·Los Angeles, United States

Read Full Article

Reuters

Pfizer files for U.S. authorization of COVID-19 pill

By Michael Erman - Pfizer Inc said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial. Pfizer said it completed submission of its application for emergency use authorization (EUA) of the drug, Paxlovid, with the U.S. Food and Drug

2 years ago·United Kingdom

Read Full Article

The Independent

Pfizer asks US officials to OK promising COVID-19 pill

Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks

2 years ago·London, United Kingdom

Read Full Article

Associated Press News

Pfizer asks US officials to OK promising COVID-19 pill

WASHINGTON (AP) — Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks.

2 years ago·United States

Read Full Article

abc News

Pfizer asks US officials to OK promising COVID-19 pill

Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks

2 years ago·United States

Read Full Article

CNN

Pfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pill

Pfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid.

2 years ago·Atlanta, United States

Read Full Article